StockIQpro
NASDAQ:SRZN

Surrozen, Inc.

Surrozen, Inc.'s revenue fell 67.4% in fiscal 2025 to $3.5M while operating margin fell to −1210.6%. Free cash flow was −$30.4M, −873.5% of revenue, and the diluted share count rose 155.0%.Summary generated from Surrozen, Inc.'s SEC filings. Latest annual report filed Mar 23, 2026.

Revenue (FY25)$3.5M
Revenue growth−67.4%
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating margin−1210.6%
Net margin−6960.8%
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flow−$30.4M
FCF margin−873.5%
Share count change+155.0%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue0130113
Operating income−54−44−46−26−42
Net income−55−36−43−64−242
Free cash flow−50−45−41−18−30

Recent filings

From SEC EDGAR

Peers

Biological products, (no diagnostic substances)